Craniomaxillofacial Devices Market Size By Product (MF Plate and Screw Fixation System, Cranial Flap Fixation System, CMF Distraction System, Temporomandibular Joint Replacement System, Thoracic Fixation System, Bone Graft Substitute System), By Implant Type (Standard Implants, Customized/Patient-specific Implants), By Location (Internal Fixators, External Fixators), By Materials (Metals, Bioabsorbable Materials, Ceramics, Polymers), By Application (Trauma Reconstruction Surgery {Cranial Surgery, Mid-face Surgery, Mandibular Surgery, Orbital Floor Reconstruction Surgery}, Orthognathic Surgery, Plastic Surgery), By Resorbability (Resorbable Fixators, Non-Resorbable Fixators), By Device Type (Reconstruction Surgery Devices, Trauma Surgery Devices), By End-use (Hospitals, Ambulatory Surgery Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Sep 2020  |  Report ID: GMI432  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 539   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Craniomaxillofacial Devices Market size valued at over USD 1.4 billion in 2019 and is expected to witness more than 7.2% CAGR from 2020 to 2026. Rise in number of sports related injuries, falls from high ground, facial injuries caused due to traffic accidents, violence, assaults, and motor car accidents are some of the major factors driving the global market growth. Furthermore, increase in preference of patients and healthcare professionals for minimally invasive craniomaxillofacial surgery will boost the market revenue.
 

Craniomaxillofacial Devices Market

Get more details on this report - Request Free Sample PDF
 

The minimally invasive surgical procedures offer several advantages while conducting reconstruction surgeries. The advantages such as faster rehabilitation and recovery, minimal blood loss and pain and shorter hospital stays will augment the industry growth. The demand and need of traditional open surgery is gradually shifting towards the use of minimally invasive techniques for trauma and reconstruction surgeries. Hence, several advantages offered by invasive surgeries owing to introduction of newer technologies will play important role in enhancing the craniomaxillofacial devices market size. However, high cost of craniomaxillofacial surgeries will be one of the major market impeding factors. It is a multi-specialty procedure and requires participation of several speciality surgeons such as neurosurgeons, plastic surgeons, as well as dental surgeons hence, resulting in making the overall procedure quite expensive.
 

The craniomaxillofacial implants fall under Class II devices of the U.S. FDA regulations. Class II devices are moderate risk devices and are required to meet special controls along with general controls such as labelling requirements. The global COVID-19 pandemic has changed the practice of oral maxillofacial surgeries (OMS). According to an article published in the National Centre for Biotechnology and Information, surgeons around the world have postponed some of the oral surgeries. During this pandemic, elective surgeries have been cancelled or postponed decreasing the risk of patients being exposed to COVID-19 in hospital, thereby supporting the hospitals in converting operating theatres into intensive care units.
 

Growing number of people suffering from craniomaxillofacial injuries caused by motor vehicle accidents, domestic accidents, work-related accidents, violence, and sports, etc. will drive the market expansion. Out of all the factors, one of the primary causes of craniofacial trauma is road traffic accidents. According to the recent statistics published by the World Health Organisation (WHO), around 1.35 million people die due to road traffic accidents every year. Most of these accidents result in causing in severe traumatic injuries to the face and cranium, requiring craniomaxillofacial devices to surgically treat them. Non-fatal road traffic accidents are also one of the major problems leading to hospitalizations or even permanent disability to major population each year.
 

Craniomaxillofacial Devices Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: USD 1,382.1 Million
Historical Data for: 2015 to 2019 Forecast Period: 2020 to 2026
Forecast Period 2020 to 2026 CAGR: 7.2% 2026 Value Projection: USD 2,208.8 Million
Pages: 539 Tables, Charts & Figures: 1176
Geographies covered (54): U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Ireland, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Sweden, Switzerland, Turkey, Ukraine, Croatia, Slovakia, China, Japan, India, Australia, South Korea, Taiwan, Indonesia, Malaysia, New Zealand, Philippines, Singapore, Thailand, Brazil, Mexico, Argentina, Colombia, Peru, Chile, South Africa, Saudi Arabia, UAE, Qatar, Kuwait, Israel
Segments covered: Product, Implant Type, Location, Materials, Application, Resorbability, Device Type and End-use
Companies covered (12): B. Braun Melsungen AG (Aesculap Implant Systems, Inc.), Cavendish Implants Ltd., CONMED Corporation, Integra Life Sciences, Johnson and Johnson, KLS Martin L.P., Medartis AG, Medtronic, OsteoMed, Stryker Corporation, TMJ Concepts, Zimmer Biomet Holdings, Inc.
Growth Drivers:
  • Increasing incidence of facial injuries and fractures
  • Growing demand for minimally invasive reconstruction surgeries
  • Rise in the prevalence of congenital facial deformities
  • Recent technological advancements in CMF implants
Pitfalls & Challenges:
  • High cost of craniomaxillofacial surgery
  • Lack of awareness in developing countries

Get more details on this report - Request Free Sample PDF
 

Frequent use of MF plate and screw fixation system will spur the craniomaxillofacial devices market growth

MF plate and screw fixation system segment revenue exceeded USD 970 million in 2019. The use of plate and screws is done in the craniomaxillofacial injury treatment as they provide the necessary tensile strength, rigidity, and effectiveness for early bone recovery. Increase in number of craniomaxillofacial surgery procedures, growing R&D activities resulting in manufacturing of technologically advanced products, growing geriatric population and minimally invasive devices will boost the industry size expansion.
 

Increase in demand and preference for customized and patient-specific implants

The craniomaxillofacial devices market for customized/patient-specific implants is poised to witness more than 7.8% growth till 2026. Anatomically shaped patient-specific implants allow customization of implants according to anatomy of the patient. Customized implants emphasize on providing personalized healthcare, to ensure that each patient receives the best treatment. The 3D printed craniomaxillofacial implants are constructed from the patient’s CT scan data. These are designed individually for each patient to reconstruct skeletal bone defects and enhance skeletal features.
 

Several advantages offered by internal fixators will boost the market growth

Internal fixators segment dominated more than 75% market share, with over USD 1 billion revenue in 2019. Rise in use of internal fixators by the healthcare professionals to reduce the complications during and after the surgery by minimizing soft-tissue disruption will enhance the craniomaxillofacial devices adoption. Several advantages offered such as enabling patient to recover fasters, shorter hospitals stay, etc. will result in higher use of internal fixators, thereby influencing the industry demand.
 

Recent developments in manufacturing of bioabsorbable materials

Bioabsorbable segment is estimated to register growth rate of 7.8% through 2026. The application of bioabsorbable craniomaxillofacial implants is becoming quite frequent and popular in craniomaxillofacial surgeries. The market for bioabsorbable craniomaxillofacial implants are expected to grow swiftly over the coming yeras due to its greater efficiency in fixation of fractures as well as for soft-tissue fixation, gradual load transfer to the healing facial tissue, reduced need for implant and associated parts removal, and radiolucency, which facilitates postoperative radiographic evaluation.
 

Rising trauma reconstruction surgeries will boost the craniomaxillofacial devices market demand

The trauma reconstruction surgery segment valuation surpassed USD 550 million in 2019. Trauma reconstruction surgery involves treating a wide range of conditions to repair and reshape facial and mandibular structures affected by birth defects, developmental abnormalities, trauma, injuries, tumours, and disease. Increase in use of craniomaxillofacial devices in trauma reconstruction will fuel the adoption rate of the craniomaxillofacial devices.
 

Growing preference of technological advanced fixation materials

Global Craniomaxillofacial Devices By Resorbability

Get more details on this report - Request Free Sample PDF
 

Resorbable fixators segment is predicted to expand at 7.7% CAGR during the forecast period. Problems pertaining to the use of metal material for fixation resulted in the advent of resorbable materials. The resorbable fixators were initially developed to avoid the need of secondary surgery for implant removal. The resorbable fixators consists of plates, screws, and meshes that are used to repair the craniomaxillofacial fracture. Also, these fixator materials have several advantages such as fast, easy, convenient, and safe to use. The resorbable implants dissolve in the body within 12 months.
 

Presence of state-of-the-art-facilities in hospitals along with the skilled healthcare professionals will impel the market expansion

The hospitals segment held around 60% craniomaxillofacial devices market share and crossed USD 841 million valuation in 2019. The major reason for high market size and surgery procedure number is the availability of technologically advanced products, modern care and recovery units, intensive care units and post-surgical support along with skilled healthcare professionals.
 

Presence of skilled professionals and recent technologies will propel the market growth

The reconstruction surgery devices segment revenue was around USD 935 million in 2019. Reconstructive surgery devices involve the use of devices that are primarily needed for plastic reconstructive surgeries. These devices are used for the reconstruction of inherited or developed craniomaxillofacial defects due to congenital abnormalities, tumour resection, and infections. Autografts are usually used for craniofacial skeletal reconstruction and the implants are used for correcting congenital defects.
 

Presence of large number of industry players and increase in number of people with trauma injuries in North America

Global Craniomaxillofacial Devices Market By Region

Get more details on this report - Request Free Sample PDF
 

U.S. dominated the North America craniomaxillofacial devices market and was worth more than USD 655 million in 2019. Birth defects such as cleft palate and other facial anomalies are quite common, costly, and critical and need facial surgeries resulting in growing demand for craniomaxillofacial devices. As per the statistics published by Centers for Disease Control and Prevention (CDC), in the U.S., congenital anomalies are one of the major causes of infant mortality and childhood morbidity affecting around 3% of all the babies born in the country. These babies born with congenital defects undergo plastic surgery or reconstruction surgery to correct or rectify the deformity.
 

Japan industry size was over USD 62 million in 2019 on account of increase in number of craniofacial trauma surgeries along with growing number of reconstructive surgeries. Additionally, Japan has one of the best healthcare infrastructures across the globe with leading hospitals and healthcare professionals for craniomaxillofacial surgeries.
 

Implementing several strategic initiatives by major market players will boost the market growth

Some of the major players operational in the industry are Stryker Corporation, KLS Martin LP, Medtronic, Zimmer-Biomet, Inc, among others. These companies are executing several significant strategies such as partnerships, collaborations, mergers, acquisitions, product launch, etc. in order to improve their geographic reach and product portfolio.
 

The craniomaxillofacial devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
 

Market, By Product

  • MF Plate and Screw Fixation System
  • Cranial Flap Fixation System
  • CMF Distraction System
  • Temporomandibular Joint Replacement System
  • Thoracic Fixation System
  • Bone Graft Substitute System

Market, By Implant Type

  • Standard Implants
  • Customized/Patient-specific Implants

Market, By Location

  • Internal Fixators
  • External Fixators

Market, By Materials

  • Metals
  • Bioabsorbable Materials
  • Ceramics
  • Polymers

Market, By Application

  • Trauma Reconstruction Surgery
    • Cranial Surgery
    • Mid-face Surgery
    • Mandibular Surgery
    • Orbital Floor Reconstruction Surgery
  • Orthognathic Surgery
  • Plastic Surgery

Market, By Resorbability

  • Resorbable Fixators
  • Non- Resorbable Fixators

Market, By Device Type

  • Reconstruction Surgery Devices
  • Trauma Surgery Devices

Market, By End-use

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Austria
    • Belgium
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • Greece
    • Hungary
    • Ireland
    • Lithuania
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Romania
    • Slovenia
    • Sweden
    • Switzerland
    • Turkey
    • Ukraine
    • Croatia
    • Slovakia
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Taiwan
    • Indonesia
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Peru
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • Kuwait
    • Israel
       

Frequently Asked Questions (FAQ) :

In 2019, global market size for craniomaxillofacial devices was worth USD 1.4 billion. The industry may depict 7.2% CAGR through 2026.
The customized/patient-specific implants may exhibit 7.8% CAGR through 2026 as patient-specific, anatomically shaped implants enable customization of implants as per patient anatomy.
U.S. dominated the North America market and was worth more than USD 655 million in 2019 and is set to witness high growth till 2026. Birth defects such as cleft palate and other facial anomalies are quite common, costly, and critical and need facial surgeries resulting in growing demand for craniomaxillofacial devices.
Internal fixators segment held an industry share of 75% and valuation of USD 1 billion. The segment will gain traction as internal fixators minimize complications during and post-surgery by reducing soft-tissue disruption.
The bioabsorbable segment may record 7.8% growth through 2026 due to increasing application and adoption of bioabsorbable implants.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Sep 2020
  • Pages: 539
  • Tables: 1150
  • Charts / Figures: 26
  • Companies covered: 12
  • Countries covered: 54

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X